Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.
D'Addio A, Curti A, Worel N, Douglas K, Motta MR, Rizzi S, Dan E, Taioli S, Giudice V, Agis H, Kopetzky G, Soutar R, Casadei B, Baccarani M, Lemoli RM. D'Addio A, et al. Among authors: casadei b. Bone Marrow Transplant. 2011 Mar;46(3):356-63. doi: 10.1038/bmt.2010.128. Epub 2010 May 31. Bone Marrow Transplant. 2011. PMID: 20577218
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.
Zinzani PL, Pellegrini C, Merla E, Ballerini F, Fabbri A, Guarini A, Pavone V, Quintini G, Puccini B, Vigliotti ML, Stefoni V, Derenzini E, Broccoli A, Gandolfi L, Quirini F, Casadei B, Argnani L, Baccarani M. Zinzani PL, et al. Among authors: casadei b. Hematol Oncol. 2013 Dec;31(4):179-82. doi: 10.1002/hon.2036. Epub 2012 Oct 29. Hematol Oncol. 2013. PMID: 23108928
Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.
Derenzini E, Stefoni V, Maglie R, Casadei B, Pellegrini C, Broccoli A, Stefani G, Fanti S, Motta MR, Narducci R, Argnani L, Zinzani PL. Derenzini E, et al. Among authors: casadei b. Biol Blood Marrow Transplant. 2013 Dec;19(12):1695-701. doi: 10.1016/j.bbmt.2013.09.004. Epub 2013 Sep 18. Biol Blood Marrow Transplant. 2013. PMID: 24055654 Free article.
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
Bonifazi F, Defrancesco I, Olivieri J, Barbato F, Lopedote P, Dicataldo M, Sessa M, Dan E, Sinigaglia B, Zazzeroni L, Rizzi S, Tassi C, Casadei B, Zinzani PL, Arpinati M. Bonifazi F, et al. Among authors: casadei b. Bone Marrow Transplant. 2021 Sep;56(9):2295-2298. doi: 10.1038/s41409-021-01359-x. Epub 2021 Jun 9. Bone Marrow Transplant. 2021. PMID: 34108674 No abstract available.
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy.
De Matteis S, Casadei B, Lolli G, Dicataldo M, Barbato F, Dan E, Paccagnella A, Sinigaglia B, Bertuzzi C, Arcari A, Zazzeroni L, Bernuzzi P, Laprovitera N, Storci G, Bertuccio SN, Ferracin M, Bonafè M, Zinzani PL, Bonifazi F. De Matteis S, et al. Among authors: casadei b. Front Immunol. 2022 Oct 6;13:994731. doi: 10.3389/fimmu.2022.994731. eCollection 2022. Front Immunol. 2022. PMID: 36275688 Free PMC article.
Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study.
Bramanti S, Mannina D, Chiappella A, Casadei B, De Philippis C, Giordano L, Navarria P, Mancosu P, Taurino D, Scorsetti M, Carlo-Stella C, Zinzani P, Santoro A, Corradini P. Bramanti S, et al. Among authors: casadei b. Bone Marrow Transplant. 2024 Oct 9. doi: 10.1038/s41409-024-02427-8. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39384870
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients.
Broccoli A, Stanzani M, Bandini G, Bonifazi F, Stefoni V, Pellegrini C, Derenzini E, Gandolfi L, Quirini F, Argnani L, Tschon M, Casadei B, Baccarani M, Zinzani PL. Broccoli A, et al. Among authors: casadei b. Leuk Lymphoma. 2013 Aug;54(8):1791-3. doi: 10.3109/10428194.2012.749470. Epub 2012 Dec 22. Leuk Lymphoma. 2013. PMID: 23153229 No abstract available.
Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.
Derenzini E, Casadei B, Broccoli A, Gandolfi L, Pellegrini C, Zinzani PL. Derenzini E, et al. Among authors: casadei b. Br J Haematol. 2014 Aug;166(4):625-8. doi: 10.1111/bjh.12894. Epub 2014 Apr 18. Br J Haematol. 2014. PMID: 24750128 Free article. No abstract available.
351 results